PHA Classroom banner

PHA Classroom has moved! Visit

>> Back to Recordings
Session Recording from PHA's 2010 9th International PH Conference

Stem Cells and PAH: Cause or Cure?

June 26, 2010 

There has been considerable interest in stem cells as a potential novel therapy for PAH, particularly for patients with advanced disease that is not responding to available therapies. Stem cells may hold the promise to repair and regenerate the small arteries in the lung which are damaged or blocked in the disease. However, stem-like cells may also contribute to vascular remodeling and therefore well designed, rigorous clinical testing is required before we can make any determination of their potential role in the treatment of this disease.

View the recording (recording will open in a new window)

View session handout (PDF)

Presenter Information

Duncan Stewart, MD (Chair)  
Todd Bull, MD
David Langleben, MD

>>If you liked this recording, you may enjoy Improving Patient Outcomes and Early Diagnosis: An Examination of the REVEAL Registry

Improving Patient Outcomes and Early Diagnosis Title Slide





Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.